Back to Journals » OncoTargets and Therapy » Volume 16

Polatuzumab Vedotin in a Patient with Refractory Burkitt Lymphoma, a Case Report

Total article views   HTML views PDF downloads Totals
3,723 Dovepress* 2,884+ 69 2,953
PubMed Central* 839 202 1,041
Totals 3,723 271 3,994
*Since 21 February 2023
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 2 3

View citations on PubMed Central and Google Scholar